Table 5.
Power of clinical trial replicates (1000 simulation runs) for the 1:2:2 age distribution
HR | Power given the distribution (%) of type 1 error rate for TTE/APCC | ||||
---|---|---|---|---|---|
100%/0% single primary endpoint: TTE | 80%/20% | 50%/50% | 20%/80% | 0%/100% single primary endpoint: APCC | |
0.60 | 0.959 | 0.952 | 0.943 | 0.914 | 0.798 |
0.65 | 0.877 | 0.855 | 0.822 | 0.777 | 0.653 |
0.67 | 0.840 | 0.819 | 0.785 | 0.735 | 0.581 |
0.70 | 0.752 | 0.723 | 0.693 | 0.645 | 0.525 |
0.75 | 0.581 | 0.556 | 0.499 | 0.439 | 0.337 |
APCC Alzheimer’s Prevention Initiative Preclinical Composite Cognitive, HR hazard ratio, TTE time to event